Regression of multifocal, skin-restricted, CD30-positive large T-cell lymphoma with interferon alfa and bexarotene therapy - 02/09/11
Doi : 10.1067/mjd.2001.117519
Abstract |
We report the case of a 43-year-old male patient with persistent multifocal, skin-restricted, CD30-positive, large T-cell lymphoma. Combination therapy of systemic interferon alfa and oral bexarotene was initiated on an experimental basis in the hope of circumventing therapies such as methotrexate, radiotherapy, or multiple-agent chemotherapy that may be required in such cases. This treatment was associated with rapid and marked regression of the patient's cutaneous lesions. (J Am Acad Dermatol 2001;45:914-8.)
Le texte complet de cet article est disponible en PDF.Plan
 | Supported in part by a grant from the National Institutes of Health CA 10815. |
| Conflict of interest: None. |
 | Reprint requests: Lars E. French, MD, Department of Dermatology, Geneva University Hospital, 24 rue Michel-du-Crest, 1211 Geneva 14 Switzerland. E-mail: french@cmu.unige.ch. |
© 2001
American Academy of Dermatology, Inc. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 45 - N° 6
P. 914-918 - décembre 2001 Retour au numéro
Article précédent
- The effect of topically applied aspirin on localized circumscribed neurodermatitis
- G. Yosipovitch, M.W. Sugeng, Y.H. Chan, A. Goon, S. Ngim, C.L. Goh
- Laser transmission through transparent membranes used in cutaneous laser treatment
- Catherine Chen, Dayna G. Diven, Susanne Lockhart, Brent Bell
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?